EUVIMEDEUVIMED entdecken
Open Access

Metabolite‐Based Endotypes of Asthma Reveal Distinct Clinical Characteristics and Immune Cell Signatures

Young Jin Pyung iD, Noeul Kang iD, Jihyun Chun iD, Keesun Yu, Da-Jeong Park, Do Yup Lee, Deog Kyeom Kim, Hyun Woo Lee iD, Cheol-Heui Yun iD

Allergy · 2026

DOI: 10.1111/all.70385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2026. Verfasst von Young Jin Pyung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agricultural Biotechnology, and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, South Korea. Hauptthemen laut MEDLINE: Asthma, Metabolomics, Metabolome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Seoul National University, Ministry of Science and ICT, South Korea, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Asthma control is commonly defined by symptom burden and recent exacerbation history. However, symptom‐based clinical stability does not necessarily reflect biological quiescence, and heterogeneity in lung function and airway structure may persist despite apparent clinical control. This study aimed to determine whether blood‐based metabolomic profiling can discriminate biologically distinct subgroups within a clinically stable asthma population.

Methods

We conducted a prospective observational study of adults with clinically stable asthma, defined by sustained symptom control and absence of recent exacerbations under maintenance inhaled corticosteroid‐based therapy. Untargeted plasma metabolomic profiling was performed using liquid chromatography–tandem mass spectrometry, and metabolite‐derived subgroups were identified by consensus clustering. Lung function, airway structure, small‐airway physiology, and peripheral immune cell profiles were compared across clusters, with associations assessed using regression analyses.

Results

Three metabolite‐derived subgroups were identified based on patterns in the relative abundance of selected representative metabolites. Symptom control and exacerbation history were comparable across clusters, whereas lung function, airway wall thickness, small‐airway physiology, and immune cell profiles differed substantially. Cluster 1 (C1; Remodeling‐prone), characterized by greater relative abundance of glycerophospholipid‐related metabolites, showed lower post‐bronchodilator FEV 1 , thicker airway walls, and increased innate lymphoid cells. Cluster 2 (C2; Biologically stable) had preserved airway structure, with thinner airway walls and higher post‐bronchodilator FEV 1 . Cluster 3 (C3; T2‐high) exhibited metabolite patterns associated with type 2 inflammatory features, including higher FeNO levels and blood eosinophil counts, while maintaining preserved airway structure.

Conclusions

Metabolomic profiling reveals biologically distinct subgroups among clinically stable asthma, indicating that symptom‐based stability does not necessarily reflect biological homogeneity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaMetabolomicsMetabolomeHumansFemaleMaleAdultBiomarkersMiddle AgedRespiratory Function TestsPhenotypeProspective Studies

Stichwörter der Autor:innen

airway remodelingasthmacluster analysisinnate lymphoid cellsmetabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Agricultural Biotechnology, and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, South Korea.
  • Division of Allergy, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, So…

ORCID-Profile: Young Jin Pyung, Noeul Kang, Jihyun Chun, Hyun Woo Lee, Cheol-Heui Yun

Förderung

  • Seoul National University
  • Ministry of Science and ICT, South Korea
  • Ministry of Health & Welfare, Republic of Korea
  • BK21 FOUR Program of the Department of Agricultural Biotechnology, Seoul National University

Zitieren

APA

Pyung, Y. J., Kang, N., Chun, J., Yu, K., Park, D. J., Lee, D. Y., Kim, D. K., Lee, H. W., & Yun, C. H. (2026). Metabolite‐Based Endotypes of Asthma Reveal Distinct Clinical Characteristics and Immune Cell Signatures. Allergy. https://doi.org/10.1111/all.70385

Vancouver

Pyung YJ, Kang N, Chun J, Yu K, Park DJ, Lee DY, et al. Metabolite‐Based Endotypes of Asthma Reveal Distinct Clinical Characteristics and Immune Cell Signatures. Allergy. 2026. doi:10.1111/all.70385

BibTeX
@article{Pyung2026,
  author = {Pyung, Young Jin and Kang, Noeul and Chun, Jihyun and Yu, Keesun and Park, Da-Jeong and Lee, Do Yup and Kim, Deog Kyeom and Lee, Hyun Woo and Yun, Cheol-Heui},
  title = {Metabolite‐Based Endotypes of Asthma Reveal Distinct Clinical Characteristics and Immune Cell Signatures},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70385}
}
Kostenlos starten →